The present study aimed to investigate this, using PA as one of the predominant mediators to induce endothelial dysfunction in HUVECs, by inducing inflammation and ROS formation and by reducing insulin- mediated NO bioavailability. The gene discussed is INS; the disease is endothelial dysfunction.